Congenital and Perinatal Varicella Infections
- PMID: 36540194
- PMCID: PMC9762609
- DOI: 10.5005/jp-journals-11002-0040
Congenital and Perinatal Varicella Infections
Abstract
Varicella-zoster virus (VZV) is a human pathogen of the α-herpesvirus family. Some fetuses infected in utero around 8-20 weeks of pregnancy show signs of congenital varicella syndrome (CVS). Infants born to mothers who develop varicella within 5 days before and 2 days after delivery can experience severe disease with increased mortality. The best diagnostic modality is polymerase chain reaction (PCR), which can be done using vesicular swabs or scrapings, scabs from crusted lesions, tissue from biopsy samples, and cerebrospinal fluid. The prevention and management of varicella infections include vaccination, anti-VZV immunoglobulin, and specific antiviral drugs. In this article, we have reviewed the characteristics of VZV, clinical manifestations, management of perinatal infections, and short- and long-term prognosis.
Keywords: Congenital varicella syndrome; Herpes zoster; Neonatal varicella; Postexposure prophylaxis; Varicella zoster immunoglobulin; Varicella–zoster virus; Vesicular rash.
Conflict of interest statement
Conflict of interest: None
Figures



References
Grants and funding
LinkOut - more resources
Full Text Sources